KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner

Autor: Lin, Xi, Ye, Rongyi, Li, Zhiming, Zhang, Bingli, Huang, Yuji, Du, Jiaxin, Wang, Bo, Meng, Hao, Xian, Hongyi, Yang, Xingfen, Zhang, Xin, Zhong, Yizhou, Huang, Zhenlie
Zdroj: In Drug Resistance Updates January 2023 66
Databáze: ScienceDirect